Antisense Oligonucleotides
(反义寡核苷酸)
反义寡核苷酸(ASOs)通常指的是短小的、人工合成的单链DNA或RNA(13至30个核苷酸)。在与靶向的mRNA或前体mRNA结合后,ASOs通过多种不同的机制调节RNA的功能。
1. 反义寡核苷酸(ASOs)能够形成一种RNA-DNA的杂合体,该杂合体成为RNaseH的作用底物,从而导致靶mRNA的降解。
2. 反义寡核苷酸(ASOs)能够通过阻断核糖体机器的立体结构来调节基因表达,这可能导致表达量降低、剪接方式的改变以及功能性蛋白质的恢复。
3. 反义寡核苷酸(ASOs)与前体mRNA的结合能够改变剪接因子的募集情况,并调控剪接过程。
反义寡核苷酸(ASOs)的首次体内应用显示出有限的临床潜力,这是因为未修饰的磷酸核糖骨架上的ASO易受内切核酸酶和外切核酸酶的快速降解作用影响。骨架和糖分子的修饰使ASO更具亲和力和稳定性。磷酰亚胺胺糖醛酸寡聚体(PMO)对核酸酶和蛋白酶的降解具有很强的抵抗力,主要用于剪接调节或翻译抑制。在核糖环的 2' 位置进行化学修饰,如 2'-O-甲基(2'-O-me)、2'-氟(2'-F)、2'-O-甲氧基乙基(2'-MOE),使得寡核苷酸能够采用类似于RNA的 C3'-内糖构象,从而使其具有热稳定性。
Antisense Oligonucleotides (176):
Cat. No. |
Product Name |
CAS No. |
Purity |
Chemical Structure |
-
- HY-109528
-
Fomivirsen sodium
|
160369-77-7 |
≥99.0% |
Fomivirsen (ISIS-2922) 是一种反义21 mer 磷酸硫寡核苷酸。Fomivirsen sodium 是一种用于巨细胞病毒视网膜炎 (CMV) 研究的抗病毒试剂 (antiviral agent)。Fomivirsen sodium 结合并降解 CMV immediate-early 2 蛋白的 mRNA,从而抑制病毒增殖。
|
-
DNA, d(P-thio)(G-C-G-T-T-T-G-C-T-C-T-T-C-T-T-C-T-T-G-C-G), eicosasodium salt
DNA, d(P-thio)(G-C-G-T-T-T-G-C-T-C-T-T-C-T-T-C-T-T-G-C-G), eicosasodium salt
-
- HY-108764
-
Mipomersen sodium
|
629167-92-6 |
|
Mipomersen sodium (ISIS 301012) 是载脂蛋白 B (apoB) 的反义寡核苷酸抑制剂。Mipomersen 具有抗 HCV 的作用,可降低 HCV 的感染性。Mipomersen sodium 可用于纯合子家族性高胆固醇血症 (HoFH) 的研究。
|
-
DNA, d(P-thio)([2'-O-(2-methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]m5rU-[2'-O-(2-methoxyethyl)]m5rC-A-G-T-m5C-T-G-m5C-T-T-m5C-[2'-O-(2-methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]rA-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]m5rC), sodium salt (1:19)
DNA, d(P-thio)([2'-O-(2-methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]m5rU-[2'-O-(2-methoxyethyl)]m5rC-A-G-T-m5C-T-G-m5C-T-T-m5C-[2'-O-(2-methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]rA-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]m5rC), sodium salt (1:19)
-
- HY-112980
-
Nusinersen
|
1258984-36-9 |
|
Nusinersen是一种反义寡核苷酸活性分子,修饰 SMN2 基因的前信使 RNA 剪接,从而促进全长SMN蛋白的生成。
|
-
RNA, [2'-O-(2-methoxyethyl)](P-thio)(m5U-m5C-A-m5C-m5U-m5U-m5U-m5C-A-m5U-A-A-m5U-G-m5C-m5U-G-G)
RNA, [2'-O-(2-methoxyethyl)](P-thio)(m5U-m5C-A-m5C-m5U-m5U-m5U-m5C-A-m5U-A-A-m5U-G-m5C-m5U-G-G)
-
- HY-112980A
-
Nusinersen sodium
|
|
99.10% |
Nusinersen sodium 是一种反义寡核苷酸活性分子,修饰 SMN2 基因的前信使 RNA 剪接,从而促进全长SMN蛋白的生成。
|
-
RNA, [2'-O-(2-methoxyethyl)](P-thio)(m5U-m5C-A-m5C-m5U-m5U-m5U-m5C-A-m5U-A-A-m5U-G-m5C-m5U-G-G), sodium salt
RNA, [2'-O-(2-methoxyethyl)](P-thio)(m5U-m5C-A-m5C-m5U-m5U-m5U-m5C-A-m5U-A-A-m5U-G-m5C-m5U-G-G), sodium salt
-
- HY-132580
-
Tofersen
|
2088232-70-4 |
|
Tofersen (BIIB067) 是一种反义寡核苷酸,可介导超氧化物歧化酶 1 (SOD1) mRNA 的 RNase H 依赖性降解,以减少 SOD1 蛋白的合成。Tofersen 可用于肌萎缩侧索硬化 (ALS) 的研究。
|
-
DNA, d([2'-O-(2-methoxyethyl)]m5rC-sp-[2'-O-(2-methoxyethyl)]rA-[2'-O-(2- methoxyethyl)]rG-sp-[2'-O-(2-methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]rA-sp-Tsp-A-sp-m5C-sp-A-sp-T-sp-T-sp-T-sp-m5C-sp-T-sp-A-sp-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]rA-sp-[2'-O-(2-methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]m5rC-sp-[2'-O-(2-methoxyethyl)]m5rU)
DNA, d([2'-O-(2-methoxyethyl)]m5rC-sp-[2'-O-(2-methoxyethyl)]rA-[2'-O-(2- methoxyethyl)]rG-sp-[2'-O-(2-methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]rA-sp-Tsp-A-sp-m5C-sp-A-sp-T-sp-T-sp-T-sp-m5C-sp-T-sp-A-sp-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]rA-sp-[2'-O-(2-methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]m5rC-sp-[2'-O-(2-methoxyethyl)]m5rU)
-
- HY-159698A
-
-
DNA, d(P-thio)([2'-O-(2-methoxyethyl)]m5rU-[2'-O-(2-methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]rA-T-T-T-A-A-T-G-A-G-m5C-[2'-O-(2-methoxyethyl)]m5rU-[2'-O-(2-methoxyethyl)]m5rU-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]rA-[2'-O-(2-methoxyethyl)]m5rC), sodium salt
DNA, d(P-thio)([2'-O-(2-methoxyethyl)]m5rU-[2'-O-(2-methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]rA-T-T-T-A-A-T-G-A-G-m5C-[2'-O-(2-methoxyethyl)]m5rU-[2'-O-(2-methoxyethyl)]m5rU-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]rA-[2'-O-(2-methoxyethyl)]m5rC), sodium salt
-
- HY-159695
-
IONIS-GCCRRx
|
1431900-72-9 |
|
IONIS-GCCRRx (ISIS 426115) 是一种糖皮质激素受体 (glucocorticoid receptor) 拮抗剂,是一种 2'-O-甲氧基乙基 (2'-MOE) 反义寡核苷酸 (ASO)。
|
-
DNA, d(P-thio)([2'-O-(2-methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]rA-[2'-O-(2-methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]m5rC-m5C-A-T-G-G-T-G-A-T-m5C-[2'-O-(2-methoxyethyl)]rA-[2'-O-(2-methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]rA-[2'-O-(2-methoxyethyl)]rG)
DNA, d(P-thio)([2'-O-(2-methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]rA-[2'-O-(2-methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]m5rC-m5C-A-T-G-G-T-G-A-T-m5C-[2'-O-(2-methoxyethyl)]rA-[2'-O-(2-methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]rA-[2'-O-(2-methoxyethyl)]rG)
-
- HY-159695A
-
IONIS-GCCRRx sodium
|
|
|
IONIS-GCCRRx (ISIS 426115) sodium 是一种糖皮质激素受体 (glucocorticoid receptor) 拮抗剂,是一种 2'-O-甲氧基乙基 (2'-MOE) 反义寡核苷酸 (ASO)。
|
-
DNA, d(P-thio)([2'-O-(2-methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]rA-[2'-O-(2-methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]m5rC-m5C-A-T-G-G-T-G-A-T-m5C-[2'-O-(2-methoxyethyl)]rA-[2'-O-(2-methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]rA-[2'-O-(2-methoxyethyl)]rG), sodium salt
DNA, d(P-thio)([2'-O-(2-methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]rA-[2'-O-(2-methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]m5rC-m5C-A-T-G-G-T-G-A-T-m5C-[2'-O-(2-methoxyethyl)]rA-[2'-O-(2-methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]rA-[2'-O-(2-methoxyethyl)]rG), sodium salt
-
- HY-132608
-
Inotersen sodium
|
1432726-13-0 |
|
Inotersen (ISIS-420915) sodium 是一种 2'-O-甲氧基乙基修饰的反义寡核苷酸。Inotersen sodium 通过靶向 TTR RNA 转录物并降低 TTR 转录物的水平来抑制转甲状腺素蛋白 (TTR) 蛋白的产生。Inotersen sodium 可用于遗传性 TTR 淀粉样变性多发性神经病的研究。
|
-
DNA, d(P-thio)([2'-O-(2-methoxyethyl)]m5rU-[2'-O-(2-methoxyethyl)]m5rC-[2'- O-(2-methoxyethyl)]m5rU-[2'-O-(2-methoxyethyl)]m5rU-[2'-O-(2-methoxyethyl)]rG-G-T-T-A-m5C-A-T-G-A-A-[2'-O-(2-methoxyethyl)]rA-[2'-O-(2-methoxyethyl)]m5rU-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]m5rC) nonadeca sodium salt
DNA, d(P-thio)([2'-O-(2-methoxyethyl)]m5rU-[2'-O-(2-methoxyethyl)]m5rC-[2'- O-(2-methoxyethyl)]m5rU-[2'-O-(2-methoxyethyl)]m5rU-[2'-O-(2-methoxyethyl)]rG-G-T-T-A-m5C-A-T-G-A-A-[2'-O-(2-methoxyethyl)]rA-[2'-O-(2-methoxyethyl)]m5rU-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]m5rC) nonadeca sodium salt
-
- HY-145727
-
Volanesorsen
|
915430-78-3 |
|
Volanesorsen (ISIS 304801) 是一种载脂蛋白CIII (apo-CIII) mRNA 的反义寡核苷酸抑制剂,可以降低甘油三酯水平并改善胰岛素抵抗。Volanesorsen 可用于高甘油三酯血症,家族性乳糜小铁血症综合征和 2 型糖尿病的研究。
|
-
DNA, d(P-thio)([2′-O-(2-methoxyethyl)]rA-[2′-O-(2-methoxyethyl)]rG-[2′-O-(2-methoxyethyl)]m5rC-[2′-O-(2-methoxyethyl)]m5rU-[2′-O-(2-methoxyethyl)]m5rU-m5C-T-T-G-T-m5C-m5C-A-G-m5C-[2′-O-(2-methoxyethyl)]m5rU-[2′-O-(2-methoxyethyl)]m5rU-[2′-O-(2-methoxyethyl)]m5rU-[2′-O-(2-methoxyethyl)]rA-[2′-O-(2-methoxyethyl)]m5rU)
DNA, d(P-thio)([2′-O-(2-methoxyethyl)]rA-[2′-O-(2-methoxyethyl)]rG-[2′-O-(2-methoxyethyl)]m5rC-[2′-O-(2-methoxyethyl)]m5rU-[2′-O-(2-methoxyethyl)]m5rU-m5C-T-T-G-T-m5C-m5C-A-G-m5C-[2′-O-(2-methoxyethyl)]m5rU-[2′-O-(2-methoxyethyl)]m5rU-[2′-O-(2-methoxyethyl)]m5rU-[2′-O-(2-methoxyethyl)]rA-[2′-O-(2-methoxyethyl)]m5rU)
-
- HY-139290
-
RGLS4326
|
2229964-07-0 |
98.28% |
RGLS4326 (RG4326) 是一种首创的 microRNA-17 (miR-17) 寡核苷酸抑制剂。RGLS4326 可用于常染色体显性多囊肾病 (ADPKD) 的研究。RGLS4326 作用于 HeLa 细胞,抑制 miR-17 功能,EC50 值为 28.3 nM。
|
-
5’-AsGsCmAfCfUfUmUsGs-3‘
5’-AsGsCmAfCfUfUmUsGs-3‘
-
- HY-147217A
-
Bepirovirsen sodium
|
2563929-84-8 |
98.44% |
Bepirovirsen sodium 是一种反义寡核苷酸,靶向所有 HBV 信使 RNAs。Bepirovirsen sodium 导致 HBV 来源的 RNAs、HBV DNA 和病毒蛋白的减少。Bepirovirsen sodium 可用于慢性 HBV 感染的研究。Bepirovirsen sodium 结合位点序列 (GCACTTCGCTTCACCTCTGC)。
|
-
DNA, d(P-thio)([2′-O-(2-methoxyethyl)]rG-[2′-O-(2-methoxyethyl)]m5rC-[2′-O-(2-methoxyethyl)]rA-[2′-O-(2-methoxyethyl)]rG-[2′-O-(2-methoxyethyl)]rA-G-G-T-G-A-A-G-m5C-G-A-[2′-O-(2-methoxyethyl)]rA-[2′-O-(2-methoxyethyl)]rG-[2′-O-(2-methoxyethyl)]m5rU-[2′-O-(2-methoxyethyl)]rG-[2′-O-(2-methoxyethyl)]m5rC), sodium salt
DNA, d(P-thio)([2′-O-(2-methoxyethyl)]rG-[2′-O-(2-methoxyethyl)]m5rC-[2′-O-(2-methoxyethyl)]rA-[2′-O-(2-methoxyethyl)]rG-[2′-O-(2-methoxyethyl)]rA-G-G-T-G-A-A-G-m5C-G-A-[2′-O-(2-methoxyethyl)]rA-[2′-O-(2-methoxyethyl)]rG-[2′-O-(2-methoxyethyl)]m5rU-[2′-O-(2-methoxyethyl)]rG-[2′-O-(2-methoxyethyl)]m5rC), sodium salt
-
- HY-132580A
-
Tofersen sodium
|
1898254-60-8 |
|
Tofersen sodium 是一种反义寡核苷酸,可介导超氧化物歧化酶 1 (SOD1) mRNA 的 RNase H 依赖性降解,以减少 SOD1 蛋白的合成。Tofersen sodium 可用于肌萎缩侧索硬化 (ALS) 的研究。
|
-
DNA, d([2'-O-(2-methoxyethyl)]m5rC-sp-[2'-O-(2-methoxyethyl)]rA-[2'-O-(2- methoxyethyl)]rG-sp-[2'-O-(2-methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]rA-sp-Tsp-A-sp-m5C-sp-A-sp-T-sp-T-sp-T-sp-m5C-sp-T-sp-A-sp-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]rA-sp-[2'-O-(2-methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]m5rC-sp-[2'-O-(2-methoxyethyl)]m5rU), sodium salt
DNA, d([2'-O-(2-methoxyethyl)]m5rC-sp-[2'-O-(2-methoxyethyl)]rA-[2'-O-(2- methoxyethyl)]rG-sp-[2'-O-(2-methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]rA-sp-Tsp-A-sp-m5C-sp-A-sp-T-sp-T-sp-T-sp-m5C-sp-T-sp-A-sp-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]rA-sp-[2'-O-(2-methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]m5rC-sp-[2'-O-(2-methoxyethyl)]m5rU), sodium salt
-
- HY-132586A
-
Viltolarsen sodium
|
|
|
Viltolarsen (NS-065/NCNP-01) sodium 是一种磷酸二酰胺吗啉代反义寡核苷酸。Viltolarsen sodium 与肌营养不良蛋白 mRNA 前体的外显子 53 结合,并通过跳过外显子 53 来恢复氨基酸开放阅读框,从而产生包含重要功能部分的缩短的肌营养不良蛋白。Viltolarsen sodium 具有用于杜氏肌营养不良症 (DMD) 研究的潜力。
|
-
RNA, [P-deoxy-P-(dimethylamino)](2',3'-dideoxy-2',3'-imino-2',3'-seco)(2'a→5')(C-C-m5U-C-C-G-G-m5U-m5U-C-m5U-G-A-A-G-G-m5U-Gm5U-m5U-C), sodium salt
RNA, [P-deoxy-P-(dimethylamino)](2',3'-dideoxy-2',3'-imino-2',3'-seco)(2'a→5')(C-C-m5U-C-C-G-G-m5U-m5U-C-m5U-G-A-A-G-G-m5U-Gm5U-m5U-C), sodium salt
-
- HY-153734
-
Inactive ASO (in vivo) sodium
|
|
|
Inactive ASO (in vivo) sodium 是一种未激活的反义寡核苷酸 (Antisense Oligonucleotide)。Inactive ASO (in vivo) sodium 在啮齿类动物基因组中无靶向性,可作为 Tofersen 的阴性对照。Inactive ASO (in vivo) sodium 含有硫代磷酸骨架修饰
和 MOE 修饰。Inactive ASO (in vivo) sodium 的胞嘧啶均为 5'甲基胞嘧啶。化学修饰的位置见参考文献。
|
-
CCTATAGGACTATCCAGGAA
CCTATAGGACTATCCAGGAA
-
- HY-145729
-
Danvatirsen
|
1402357-06-5 |
|
Danvantisen 是一种靶向 STAT3 的反义寡核苷酸,具有潜在的抗肿瘤活性。Danvantisen 与 STAT3 mRNA结合,从而抑制转录本的翻译。抑制 STAT3 的表达可诱导肿瘤细胞凋亡,抑制肿瘤细胞生长。
|
-
DNA, d(P-thio)([(5′ξ)-2′,5′-anhydro-6′-deoxy-4′-C-(hydroxymethyl)-α-L-lyxo-hexofurano]m5C-(3′→4′)-[(5′ξ)-2′,5′-anhydro-6′-deoxy-4′-C-(hydroxymethyl)-α-L-lyxo-hexofurano]m5U-(3′→4′)-[(5′ξ)-2′,5′-anhydro-6′-deoxy-4′-C-(hydroxymethyl)-α-L-lyxo-hexofurano]A-T-T-T-G-G-A-T-G-T-m5C-(3′→4′)-[(5′ξ)-2′,5′-anhydro-6′-deoxy-4′-C-(hydroxymethyl)-α-L-lyxo-hexofurano]A-(3′→4′)-[(5′ξ)-2′,5′-anhydro-6′-deoxy-4′-C-(hydroxymethyl)-α-L-lyxo-hexofurano]G-(3′→4′)-[(5′ξ)-2′,5′-anhydro-6′-deoxy-4′-C-(hydroxymethyl)-α-L-lyxo-hexofurano]m5C)
DNA, d(P-thio)([(5′ξ)-2′,5′-anhydro-6′-deoxy-4′-C-(hydroxymethyl)-α-L-lyxo-hexofurano]m5C-(3′→4′)-[(5′ξ)-2′,5′-anhydro-6′-deoxy-4′-C-(hydroxymethyl)-α-L-lyxo-hexofurano]m5U-(3′→4′)-[(5′ξ)-2′,5′-anhydro-6′-deoxy-4′-C-(hydroxymethyl)-α-L-lyxo-hexofurano]A-T-T-T-G-G-A-T-G-T-m5C-(3′→4′)-[(5′ξ)-2′,5′-anhydro-6′-deoxy-4′-C-(hydroxymethyl)-α-L-lyxo-hexofurano]A-(3′→4′)-[(5′ξ)-2′,5′-anhydro-6′-deoxy-4′-C-(hydroxymethyl)-α-L-lyxo-hexofurano]G-(3′→4′)-[(5′ξ)-2′,5′-anhydro-6′-deoxy-4′-C-(hydroxymethyl)-α-L-lyxo-hexofurano]m5C)
-
- HY-149906
-
-
DNA, d(P-thio)(C-T-C-T-C-G-C-A-C-C-C-A-T-C-T-C-T-C-T-C-C-T-T-C-T)
DNA, d(P-thio)(C-T-C-T-C-G-C-A-C-C-C-A-T-C-T-C-T-C-T-C-C-T-T-C-T)
-
- HY-108753
-
-
RNA, [P-deoxy-P-(dimethylamino)](2',3'-dideoxy-2',3'-imino-2',3'-seco)(2'a→5')(C-m5U-C-C-A-A-C-A-m5U-C-A-A-G-G-A-A-G-A-m5U-G-G-C-A-m5U-m5U-m5U-C-m5U-A-G), 5'-[P-[4-[[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]carbonyl]-1-piperazinyl]-N,N-dimethylphosphonamidate]
RNA, [P-deoxy-P-(dimethylamino)](2',3'-dideoxy-2',3'-imino-2',3'-seco)(2'a→5')(C-m5U-C-C-A-A-C-A-m5U-C-A-A-G-G-A-A-G-A-m5U-G-G-C-A-m5U-m5U-m5U-C-m5U-A-G), 5'-[P-[4-[[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]carbonyl]-1-piperazinyl]-N,N-dimethylphosphonamidate]
-
- HY-143230
-
Custirsen
|
890056-27-6 |
|
Custirsen 是一种高度特异性的反义寡核苷酸,可抑制 clusterin的产生,clusterin 是一种抗凋亡蛋白,在化疗反应中上调表达,并导致耐药性。
|
-
DNA, d(P-thio)([2′-O-(2-methoxyethyl)]m5rC-[2′-O-(2-methoxyethyl)]rA-[2′-O-(2-methoxyethyl)]rG-[2′-O-(2-methoxyethyl)]m5rC-A-G-C-A-G-A-G-T-C-T-T-C-A-[2′-O-(2-methoxyethyl)]m5rU-[2′-O-(2-methoxyethyl)]m5rC-[2′-O-(2-methoxyethyl)]rA-[2′-O-(2-methoxyethyl)]m5rU)
DNA, d(P-thio)([2′-O-(2-methoxyethyl)]m5rC-[2′-O-(2-methoxyethyl)]rA-[2′-O-(2-methoxyethyl)]rG-[2′-O-(2-methoxyethyl)]m5rC-A-G-C-A-G-A-G-T-C-T-T-C-A-[2′-O-(2-methoxyethyl)]m5rU-[2′-O-(2-methoxyethyl)]m5rC-[2′-O-(2-methoxyethyl)]rA-[2′-O-(2-methoxyethyl)]m5rU)
-
- HY-153495A
-
-
DNA, d(P-ethyl)(A-T-A-T-T-T-G-G-C-G-A-T-G-G-C-T-T-C), sodium salt
DNA, d(P-ethyl)(A-T-A-T-T-T-G-G-C-G-A-T-G-G-C-T-T-C), sodium salt